AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Spectris PLC

Earnings Release Jul 5, 2022

4698_rns_2022-07-05_83065783-b283-4500-a254-153cf2b29ee5.html

Earnings Release

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2816R

Spectris PLC

05 July 2022

Divestment of Omega Engineering completed

5 July 2022 - Further to the announcement of 19 April 2022, Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, today announces that the divestment of Omega Engineering ('Omega') to Arcline Investment Management for $525 million has completed, following receipt of the required regulatory approvals.

Following completion of the sale of Omega, Spectris will be made up of three businesses:

Malvern Panalytical, HBK and Industrial Solutions, focused on high precision measurement solutions.

As a result, in the Group's upcoming first half results on 1 August, Omega will be reported as a discontinued operation under IFRS 5 and therefore excluded from the segmental analysis. The six months ended 30 June 2021 and twelve months ended 31 December 2021 will be restated to show continuing operations, including a reclassification of continuing head office expenses that were previously allocated to Omega being re-allocated to the three remaining businesses. These totalled

approximately £2.2 million in the first half of 2021 and £4.8 million for the full year.

A summary of the Group's re-stated sales and adjusted operating profit is presented below. This is still subject to final adjustments, with the full details to be provided in the upcoming first half results.

Malvern Panalytical HBK Omega Industrial Solutions Total
2021 half year by segment H1 2021 H1 2021 restated H1 2021 H1 2021 restated H1 2021 H1 2021 restated H1 2021 H1 2021 restated H1 2021 H1 2021 restated
Sales (£m) 178.5 178.5 188.0 188.0 64.3 - 171.0 171.0 601.8 537.5
Adjusted operating profit (£m) 23.0 22.3 22.5 21.7 6.5 - 24.8 24.1 76.8 68.1
Adjusted operating margin (%) 12.9% 12.5% 12.0% 11.5% 10.1% - 14.5% 14.1% 12.8% 12.7%
Malvern Panalytical HBK Omega Industrial Solutions Total
2021 full year by segment FY 2021 FY 2021 restated FY 2021 FY 2021 restated FY 2021 FY 2021 restated FY 2021 FY 2021 restated FY 2021 FY 2021 restated
Sales (£m) 401.2 401.2 425.5 425.5 129.0 - 336.3 336.3 1,292.0 1,163.0
Adjusted operating profit (£m) 72.2 70.6 65.0 63.3 15.0 - 57.2 55.7 209.4 189.6
Adjusted operating margin (%) 18.0% 17.6% 15.3% 14.9% 11.6% - 17.0% 16.6% 16.2% 16.3%

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Contacts:

Spectris plc

Siobhán Andrews

Head of Corporate Affairs

+44 20 4551 4549/+44 7920 230093

Tulchan Communications

Martin Robinson

Giles Kernick

+44 20 7353 4200

About Spectris

Spectris' global group of businesses are focused on delivering value beyond measure for all our stakeholders. We target global, attractive and sustainable markets, where growth and high returns are supported by long-term drivers. Precision is at the heart of what we do. We provide customers with expert insight through our advanced instruments and test equipment, augmented by the power of our software and services. This equips customers with the ability to reduce time to market, improve processes, quality and yield. In this way, Spectris know-how creates value for our wider society, as our customers design, develop, test and manufacture their products to make the world a cleaner, healthier and more productive place. Headquartered in London, United Kingdom, the Company employs approximately 7,350 people located in more than 30 countries. For more information, visit www.spectris.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISSSMFWLEESEIW

Talk to a Data Expert

Have a question? We'll get back to you promptly.